Carlos Camps (C Camps Herrero, Carlos Camps Herrero)

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Expert review of molecular diagnostics

Consorci Hospital General Universitari de València

Universitat de València (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Consorci Hospital General Universitari de València

Spain

Coordinador Medico Unidad Investigación Fases Tempranas

Universitat de València

Spain

Profesor Titular del Departamento de Medicina :: Departamento de Medicina

Consorci Hospital General Universitari de València

Spain

Jefe del Servicio de Oncología Médica :: Servicio de Oncología Médica

Education History

Universitat de València

Spain

PHD :: Facultad de Medicina

Publications

Adrianna Janik, María Torrente, Luca Costabello, Virginia Calvo, Brian Walsh, Carlos Camps, Sameh K Mohamed, Ana Laura Ortega, Vít Nováček, Bartomeu Massutí, Pasquale Minervini, M Rosario Garcia Campelo, Edel Del Barco, Joaquim Bosch-Barrera, Ernestina Menasalvas, Mohan Timilsina, Mariano Provencio Pulla
Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer. JCO clinical cancer informatics 7 (2023)
Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach, Marais Mosqueda, Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps, Eloísa Jantus-Lewintre
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer. International journal of molecular sciences 24 (24) (2023)
Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach, Marais Mosqueda, Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps, Eloísa Jantus-Lewintre
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer. International journal of molecular sciences 24 (24) (2023)
Elena Duréndez-Sáez, Silvia Calabuig-Fariñas, Susana Torres-Martínez, Andrea Moreno-Manuel, Alejandro Herreros-Pomares, Eva Escorihuela, Marais Mosqueda, Sandra Gallach, Ricardo Guijarro, Eva Serna, Cristian Suárez-Cabrera, Jesus M Paramio, Ana Blasco, Carlos Camps, Eloísa Jantus-Lewintre
Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer. Cancers 14 (13) (2022)
Bianca Tabita Muresan, Martín Núñez Abad, Ana Artero, Jaime Rios Rios, Alberto Jacobo Cunquero-Tomás, Vega Iranzo González-Cruz, Javier Garrido, Ana Jiménez-Portilla, Carlos Camps, Carlos J Sánchez Juan
Relation of Malnutrition and Nosocomical Infections in Cancer Patients in Hospital: An Observational Study. Journal of nutrition and metabolism 2022 (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena, Susana Torres-Martínez, Clara García González, José Ángel García-García, Vega Iranzo González-Cruz, Carlos Camps
Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer. Cancers 14 (2) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Carlos Camps, Rafael López, Antonio Antón, Enrique Aranda, Alfredo Carrato, Juan Jesús Cruz Hernández, Alberto Jacobo Cunquero-Tomás, Eduardo Díaz-Rubio, Margarita Feyjóo, Jesús García-Foncillas, Pere Gascón, Ilse Lugo, Álvaro Rogado, Vicente Guillem
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications. JCO oncology practice 17 (8) (2021)
Carlos Camps, N Batista, N Díaz Fernández, Y Escobar Álvarez, A Gonzalo Gómez, D Isla Casado, A Salud, J Terrasa Pons, V Guillem Porta
Breakthrough cancer pain: review and calls to action to improve its management. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (8) (2020)
Susana Torres, Álvaro González, Alberto Jacobo Cunquero Tomas, Silvia Calabuig-Fariñas, Macarena Ferrero, Danielle Mirda, Rafael Sirera, Eloísa Jantus-Lewintre, Carlos Camps
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer. Expert review of molecular diagnostics 20 (6) (2020)
Andrea Moreno-Manuel, Silvia Calabuig-Fariñas, Antonia Obrador-Hevia, Ana Blasco, Amaya Fernández-Díaz, Rafael Sirera, Carlos Camps, Eloísa Jantus-Lewintre
dPCR application in liquid biopsies: divide and conquer. Expert review of molecular diagnostics 21 (1) (2020)
Carlos Camps, J J Reina Zoilo, D Monge Martín, F Caballero Martínez, V Guillem Porta, E Aranda Aguilar, A Carrato Mena, E Díaz-Rubio García, J García-Foncillas López, M Feijóo Saus, R López López
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (3) (2018)

Carlos Camps.css-eqlu8i{font-size:small;padding-left:4px;} (C Camps Herrero, Carlos Camps Herrero)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos Camps (C Camps Herrero, Carlos Camps Herrero)